Schlatter C - Search Results

1

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients.

Gligorov J, Ataseven B, Verrill M, De Laurentiis M, Jung KH, Azim HA, Al-Sakaff N, Lauer S, Shing M, Pivot X; SafeHer Study Group. Gligorov J, et al. Eur J Cancer. 2017 Sep;82:237-246. doi: 10.1016/j.ejca.2017.05.010. Epub 2017 Jun 16. Eur J Cancer. 2017. PMID: 28625777 Clinical Trial.

2

Altered gene expression by sedaxane increases PSII efficiency, photosynthesis and growth and improves tolerance to drought in wheat seedlings.

Ajigboye OO, Lu C, Murchie EH, Schlatter C, Swart G, Ray RV. Ajigboye OO, et al. Among authors: schlatter c. Pestic Biochem Physiol. 2017 Apr;137:49-61. doi: 10.1016/j.pestbp.2016.09.008. Epub 2016 Sep 29. Pestic Biochem Physiol. 2017. PMID: 28364804 Free article.

3

Evaluation of the Faraday angle by numerical methods and comparison with the Tore Supra and JET polarimeter electronics.

Brault C, Gil C, Boboc A, Spuig P; JET-EFDA Contributors. Brault C, et al. Rev Sci Instrum. 2011 Apr;82(4):043502. doi: 10.1063/1.3570621. Rev Sci Instrum. 2011. PMID: 21678660

4

Detecting non-maxwellian electron velocity distributions at JET by high resolution Thomson scattering.

Beausang KV, Prunty SL, Scannell R, Beurskens MN, Walsh MJ, de la Luna E; JET EFDA Contributors. Beausang KV, et al. Rev Sci Instrum. 2011 Mar;82(3):033514. doi: 10.1063/1.3567785. Rev Sci Instrum. 2011. PMID: 21585113

5

Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Schlatter C, Egger SS, Tchambaz L, Krähenbühl S. Schlatter C, et al. Drug Saf. 2009;32(7):561-78. doi: 10.2165/00002018-200932070-00003. Drug Saf. 2009. PMID: 19530743 Review.

6

Dose adaptation of antineoplastic drugs in patients with liver disease.

Tchambaz L, Schlatter C, Jakob M, Krähenbühl A, Wolf P, Krähenbühl S. Tchambaz L, et al. Among authors: schlatter c. Drug Saf. 2006;29(6):509-22. doi: 10.2165/00002018-200629060-00004. Drug Saf. 2006. PMID: 16752933 Review.

7

[Adnexitis and pelvic inflammatory disease].

Lauper U, Schlatter C. Lauper U, et al. Among authors: schlatter c. Gynakol Geburtshilfliche Rundsch. 2005 Jan;45(1):14-8. doi: 10.1159/000081712. Gynakol Geburtshilfliche Rundsch. 2005. PMID: 15644636 German.

8

Covalent binding of agaritine to DNA in vivo.

Shephard SE, Schlatter C. Shephard SE, et al. Among authors: schlatter c. Food Chem Toxicol. 1998 Nov;36(11):971-4. doi: 10.1016/s0278-6915(98)00076-3. Food Chem Toxicol. 1998. PMID: 9771560

9

Distribution and pharmacokinetics of alkylphenolic compounds in primary mouse hepatocyte cultures.

Müller S, Schmid P, Schlatter C. Müller S, et al. Among authors: schlatter c. Environ Toxicol Pharmacol. 1998 Aug 4;6(1):45-8. doi: 10.1016/s1382-6689(98)00018-0. Environ Toxicol Pharmacol. 1998. PMID: 21781880

10

Evaluation of the estrogenic potency of nonylphenol in non-occupationally exposed humans.

Müller S, Schmid P, Schlatter C. Müller S, et al. Among authors: schlatter c. Environ Toxicol Pharmacol. 1998 Aug 4;6(1):27-33. doi: 10.1016/s1382-6689(98)00015-5. Environ Toxicol Pharmacol. 1998. PMID: 21781878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page